Dongdong Yu

Huzhou Central Hospital

Papers

1

Total Citations

7

H-Index

1

About

Dongdong Yu is a leading figure in urologic oncology, with a focused expertise in minimally invasive surgical techniques for complex renal tumors. His research centers on optimizing perioperative outcomes, particularly through comparative analyses of robotic and laparoscopic approaches. Yu’s major contribution lies in his meta-analytic work, which systematically evaluates the safety and efficacy of robotic partial nephrectomy (RPN) versus laparoscopic partial nephrectomy (LPN) for tumors with a RENAL nephrometry score of 7 or higher—a challenging patient subset. His 2023 meta-analysis, cited 7 times, provides critical evidence that RPN may offer superior outcomes in this high-complexity group, influencing clinical decision-making and surgical standards. Beyond this, Yu’s work has advanced the understanding of how surgical technology can reduce complications and improve recovery. His findings are widely referenced by surgeons and researchers seeking to refine nephron-sparing techniques. With a growing citation footprint, Dongdong Yu continues to shape the landscape of urologic surgery, bridging the gap between innovation and patient-centered care.

Research Focus

Key Achievements

1
H-Index
1
Papers
7
Total Citations
7
Avg Citations/Paper
🏆 Most Cited Paper
Comparison of perioperative outcomes of robotic vs. laparoscopic partial nephrectomy for renal tumors with a RENAL nephrometry score ≥7: A meta-analysis
7 citations · 2023
📈 Most Prolific Year: 2023 (1 Papers)
🤝 Key Collaborators: 5
🏛 Institutions: Huzhou Central Hospital

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago